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Abstract 
Fast swelling highly porous superporous hydrogels (SPH) are synthesized 
through a method utilizing rapid solution polymerization of acrylic acid for 
development of gastric retention devices. The swelling property, mechanical 
strength and release profile of SPH containing Metformin was investigated 
by changing the amount of crosslinking agents, (Bis) and AcDiSol. The 
results indicate that swelling ratio increases in the concentration range of 1%-
2.5% w/v of Bis while beyond 2.5% w/v the swelling ratio slightly decreases 
but is not significant. Mechanical strength of the SPH was significantly 
increased by increasing the concentration of Bis from 1%-3.5% w/v. The 
release kinetics of SPH containing different crosslinker concentrations was 
measured in 0.1NHCl which was found to be consistent with the expected 
swelling behavior. AcDiSol was an important factor in maintaining the 
capillary structure required for fast swelling. Increase in AcDiSol resulted in 
decrease in swelling ratio of composite from 98.36±0.5% to 85.57±0.4%. As 
the amount of AcDiSol increases the mechanical strength increases due to 
increased cross linking density of the Superporous Hydrogel. This study 
indicates that superporous hydrogel composite possessed two properties 
necessary for gastric retention i.e., fast swelling and mechanical strength. 
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Introduction  
Drug absorption from gastrointestinal tract is a 
complex procedure and is subject to many variables. 
Several methods are applied for increasing the 
residence time of dosage forms in the gastrointestinal 
(GI) tract, including magnetic systems [1], floating 
system, expandable system and mucoadhesive systems 
[2]. In addition, superporous hydrogels have also been 
developed for prolonging the residence time of delivery 
systems in the GI tract [3]. A superporous hydrogel 
(SPH)  is  a  3-dimensional  network  of  a   hydrophilic  
 
polymer that absorbs a large amount of water in a very 
short period of time due to the presence of 
interconnected microscopic pores [4]. Because of the 
porous structure, SPHs also possess hundreds of times 
more surface area and shorter diffusion distance than 
conventional hydrogels. These features allow dried 
SPHs to swell very fast to a very large size on contact 
with water. Because of these unique properties, SPHs 
were initially proposed to develop gastric retention 
devices for extending the gastric residence time of 
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drugs for achieving long-term, oral-controlled drug 
delivery [5].
 
 
Although SPHs have unique properties that make them 
useful as a platform for gastric retention, the weak 
mechanical properties of the fully swollen SPHs have 
been a main hurdle limiting their practical applications. 
One approach to improve the mechanical properties 
was making SPH composites by adding composite 
material AcDiSol and varying the amount of cross 
linker.6 The main role of Ac-Di-Sol was to increase the 
physical cross linking of polymer chains so that the 
porous structure was maintained during drying of the 
SPHs. 
Metformin is an anti-hyperglycemic agent, which 
improves glucose tolerance in type II diabetes. It has 
been reported that the absolute bioavailability of 
metformin when given orally is 50-60%. Biological 
half life of metformin is 1.5-1.6 hr and the main site of 
absorption is proximal small intestine. A super porous 
hydrogel composite was planned for metformin. Such a 
system when administered would remain buoyant on 
gastric fluid for a prolonged period of time and the 
drug would be available in the dissolved form at the 
main site of its absorption. This would lead to 
improvement in the bioavailability of the drug. In this 
way it stands an advantage over conventional dosage 
forms, which need to be administered twice or thrice a 
day. 
The objective of this study was to improve the swelling 
and mechanical properties of superporous hydrogels 
(SPHs) by varying the amount of cross linker and 
AcDiSol in such a way so as to develop gastric 
retention devices for long-term gastric drug delivery. 
 
Materials and methods 
Materials 
Metformin was obtained as a gift sample from 
Bestochem Pharma Ltd. Haridwar, India. Acrylic acid 
(AA), N,N’methylene Bisacrylamide (Bis), Pluronic F-
68, N,N,N',N'-tetramethylene diamine (TEMED) were 
obtained from HiMedia lab. Pvt. Ltd. Mumbai, India.   
Acrylamide (AM), 3-sulfopropyl acrylate potassium 
salt (SPAK), ammonium per sulfate (APS) and Sodium 
bicarbonate were obtained from S.D. fine chem Ltd., 
Mumbai, India. 
 
Synthesis of superporous hydrogel composite 
SPH were synthesized using various vinyl monomers. 
The monomers used in this study were AM, SPAK, and 
neutralized acrylic acid [the mixture of acrylic acid and 
sodium acrylate, pH (5.1). To make the SPH the 
following components were added sequentially to a 
glass test tube: 50% AM and 50% SPAK as monomers, 
(2.5%) Bisacrylamide as crosslinker, 10% Pluronic F-
68 as foam stabilizer, 50% AA, 20% APS, and 20% 
TEMED as redox initiator pair, deionized distilled 
water (DDW),  and 100 mg of sodium bicarbonate. The 
test tube was shaken to mix the solution after each 
ingredient was added. The pH of the AA was adjusted 
to 5 by using 2 M NaOH. The drug Metformin 
Hydrochloride (MH) 150mg, was added before 
addition of sodium bicarbonate. Cross-carmellose 
sodium was added as composite material. Sodium 
bicarbonate was added to the monomer solutions and 
mechanically stirred using a spatula for several seconds 
to evenly distribute the generating gas bubbles. Sodium 
bicarbonate was used as a foaming agent which 
increased the pH of the solution and accelerated the 
polymerization. The synthesized SPH was retrieved 
from the test tubes by adding 2 mL of absolute ethanol. 
The absence of monomers was ensured 
spectrometrically by ensuring that the water of the 
washings did not contain any trace of monomers. The 
SPH was dried in an oven at 60°C for 6 hours [5-8]. 
 
Swelling studies 
Swelling time 
Swelling time was calculated by immersing the 
hydrogels in deionized water as well as 0.1N HCl and 
calculating the time required to attain equilibration in 
swelling. 
 
Swelling ratio 
The dried SPH was allowed to hydrate in excess of 
deionised distilled water at room temperature. The 
weight of hydrating sample was measured at time 
intervals, after excess water was removed by gentle 
blotting. The swelling ratio was defined as: 
Qs = Ws − WdX100 
                              Wd 
Where Ws is the weight of the swollen super porous 
hydrogel Composite and Wd is the 
Weight of the dried super porous hydrogel Composite 
[5, 6, 9]. 
 
 
Table 1. Optimization of cross-linking agent 
S. 
No 
EXCIPIENTS CH1 CH2 CH3 CH4 CH5 CH6 
1 AM(1200µl) 50% 50% 50% 50% 50% 50% 
2 AA(30µl) 50% 50% 50% 50% 50% 50% 
3 Bis (450µl) 1% 1.5% 2% 2.5% 3% 3.5% 
4 SPAK(900µl) 50% 50% 50% 50% 50% 50% 
5 PLURONIC     F -68 (90µl) 10% 10% 10% 10% 10% 10% 
6 APS(45µl) 20% 20% 20% 20% 20% 20% 
7 TEMED(45µl) 20% 20% 20% 20% 20% 20% 
8 NaHCO3(mg) 100 100 100 100 100 100 
9 Ac-Di-Sol(mg) 75 75 75 75 75 75 
11 MH(mg) 150 150 150 150 150 150 
 
Mechanical strength 
Mechanical strength of dried SPH was measured by 
applying the weight on swelled Superporous 
hydrogels, until the hydrogels fractured [5, 6]. 
 
Table 2. Optimization of Ac-Di-Sol 
 
In -vitro drug release studies 
Metformin Hydrochloride release from CH was 
studied using USP type I (Veego, DA-6DR). The 
dissolution medium used was 0.1 N HCl and the 
study was carried out for up to 12 h. The rotational 
speed was maintained at 50 rpm and the temperature 
at 37 ± 0.50C. Aliquots of dissolution medium were 
withdrawn periodically and were analyzed using UV-
Visible spectrophotometer (Shimadzu, UV-1700) [5, 
6, 10].  
 
 
Release kinetics optimized of formulation 
Korsmeyer et al (1983) derived a simple relationship 
which described drug release from a polymeric 
system Eq. (5). To find out the mechanism of drug 
release, first 60 % drug release data was fitted in 
Korsmeyer- Peppas model: 
Mt/ M∞ = K t n 
where, Mt/ M∞ is fraction of drug released at time t, 
K is the rate constant and n is the release exponent. 
The n value is used to characterize different release 
mechanisms as given in table for cylindrical shape 
formulations. 
 
Scanning electron microscope (SEM) 
Porous structures of Superporous Hydrogel 
Composites were examined using a scanning electron 
microscope (SEM). Dried superporous hydrogels  
were cut in such a way to expose their inner structure, 
coated with a thin layer of palladium gold alloy in 
hummer 1 Sputter Coater, and imaged in a SEM 
(JSM-840, JEOL) 
 
Result and discussion 
Optimization of cross linking agent 
To optimize the cross linking agent Bis (Table 1) 
various concentrations were  evaluated on the basis of 
physical character, apparent density, swelling studies 
(swelling time and swelling ratio), mechanical 
strength and percentage cumulative drug release.  
 
Table No.3 Effect of crosslinking agent on swelling 
ratio and mechanical strength 
 
Swelling studies 
Swelling time(min) 
Formulation 
Code 
In 
distilled 
water 
In 0.1N 
HCl 
Swelling 
ratio (n=3)  
Mean ± S.D 
Mechanical 
Strength  (gm) 
CH1 30 28 73 ± 0.6 115 
CH2 22 18 83 ± 0.8 135 
CH3 16 14 89 ± 0.6 175 
CH4 10 10 92 ± 0.4 245 
CH5 9 8 91.3 ± 0.7 249 
CH6 8 6 90.8 ± 0.7 250 
Effect of cross linking agent on swelling time and 
swelling ratio 
S. 
N0. 
EXCIPI-
ENT CH4a CH4b CH4c CH4d CH4e CH4f 
1 AM (50 %) (μl) 1200 1200 1200 1200 1200 1200 
2 AA (50 %) (μl) 30 30 30 30 30 30 
3 Bis (2.5%) (μl) 450 450 450 450 450 450 
4 SPAK (50 %) (μl) 900 900 900 900 900 900 
5 
PLURONI
C F-68    
(10 %) (μl) 
90 90 90 90 90 90 
6 APS (20 %) (μl) 45 45 45 45 45 45 
7 Ac- Di- sol (mg) 50 75 100 125 150 175 
8 TEMED   (20%) (μl) 45 45 45 45 45 45 
9 NaHCO3  (mg) 100 100 100 100 100 100 
10 MH (mg) 150 150 150 150 150 150 
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To investigate the effect of crosslinker on the 
swelling characteristics of the gel the concentration of 
Bis in the feed mixture was varied in the range 1%-
3.5% w/v. The results are recorded in Table No.3 
which clearly indicates that the swelling ratio 
increases when the concentration of Bis is in the 
range 1%-2.5% w/v, while beyond 2.5% w/v the 
swelling ratio slightly decreases. The initial increase 
in the swelling time is because Bis itself is a 
hydrophilic monomer and, therefore, the swelling 
ratio increases with increasing concentration of Bis. 
However beyond 2.5% w/v, the slight decrease is due 
to increasing cross linking density in the hydrogel 
which lowers the average molecular weight between 
cross links and this curtails the free volumes 
accessible to the penetrant water molecules. At higher 
amounts of Bis the hydrogel network chains become 
so inflexible that the swelling ratio is independent of 
the amount of Bis concentration. 
 
 
 
 Figure 1. Effect of crosslinking agent on 
Cummulative Drug Release of drug. 
 
Effect of cross linking agent on mechanical strength 
The mechanical strength of the SPH was significantly 
increased by increasing the concentration of Bis from 
1%-3.5% w/v, whereas the mechanical strength of the 
hydrogel with 2.5% to3.5% w/v of Bis was not 
significantly different. Thus the hydrogel with 2.5% 
w/v Bis was selected for further studies. (Table 3) 
 
Effect of cross linking agent In- vitro Drug Release  
The release kinetics of Superporous Hydrogel 
containing different crosslinker concentrations were 
measured in 0.1NHCl. The result is shown in figure 1 
which is consistent with the expected swelling 
behavior.  
 
 
 
Figure 2. Zero order Release Kinetics of optimized 
formulation [CH4f]. 
 
It is revealed from the figure 3 that a maximum 
release rate was observed at 2.5% w/v of Bis while, 
with increasing Bis the released amount slightly 
decreases, although not significantly. This is due to a 
densely cross linked gel from which the release of a 
drug is more difficult than from a loosely cross linked 
network. 
 
 
 
Figure 3. First order Release Kinetics of optimized 
formulation [CH4f]. 
 
Optimization of Ac- Di –Sol 
Effect of Ac- Di -Sol on Swelling Time and Swelling 
Ratio 
Ac- Di –Sol was an important factor in maintaining 
the capillary structure required for fast swelling. 
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Table 4. Effect of Ac-Di-Sol on Swelling Ratio and 
Mechanical strength 
 
Swelling studies 
Swelling time(min) 
Formulation  
Code 
 
 In 
distilled 
water 
In 
0.1N 
HCl 
Swelling ratio 
(n=3) 
Mean ± S.D 
Mechanical 
Strength  
(gm) 
CH4a 24 16 98.36 ± 0.5 245 ± 1.2 
CH4b 18 12 95.12 ± 0.6 255 ± 1.8 
CH4c 15 14 93.29 ± 0.2 275 ± 1.3 
CH4d 12 10 92.29 ± 0.5 280 ± 1.4 
CH4e 10 8 89.07 ± 0.3 300 ± 1.5 
CH4f 6 3 85.57 ± 0.4 320 ± 1.3 
 
The swelling time of Superporous Hydrogel 
Composite was reduced to 16 min, 12 min, 14 min, 10 
min, 8 min, and 3 min by the addition of 50 mg, 75 
mg, 100 mg, 125 mg, 150 mg, 175 mg of Ac- Di –
Sol. Increase in Ac- Di –Sol also resulted in decrease 
in swelling ratio of composite from 98.36±0.5% to 
85.57±0.4% (Table 4).  
 
 
 
Figure 4. Korsemeyer-Peppas Kinetics of 
optimized formulation [CH4f]. 
 
This indicates that Ac- Di –Sol improved the 
structural integrity of the superporous hydrogel by 
entanglement of the polymer chains with the Ac-Di-
Sol fibres. The overall cross linking density increased 
thereby decreasing the swelling ratio. It also provides 
intrafibers capillary channels in its hollow lumen. 
This effect causes reduction in swelling time. 
 
Effect of Ac- Di –Sol on Mechanical Strength 
One of the most important requirements for a gastric 
retention Superporous Hydrogel is its structural 
integrity.  
 
 
 
Figure 5. Higuchi kinetics of optimized 
formulation [CH4f]. 
 
A superporous hydrogel should be able to withstand 
the pressure expected in the stomach during repeated 
gastric contraction. As the amount of Ac-Di-Sol 
increases the mechanical strength increases due to 
increased cross linking density of the Superporous 
Hydrogel. When more than 175mg of Ac-Di-Sol was 
incorporated, due to increase of solution viscosity 
good mixing of all the ingredients becomes difficult 
(Table 4). Thus 175mg of Ac-Di-Sol was used as the 
optimum concentration. 
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Figure 6. SEM structure of optimized batch 
[CH4f] outer surface. 
Release kinetics 
The release profile of optimized formulation (Figure 
2-5) CH4f follows Korsmeyer-Peppas equation and 
the coefficient of regression (R2) was found to be 
0.976. The value of the release exponent (n) in 
Metformin Hydrochloride Superporous Hydrogel 
Composite (CH4f) was obtained as 0.598. As per 
diffusion mechanism, anomalous non fickian 
diffusion was observed. Thus, it can be concluded 
that the optimized formulation follows the 
Korsmeyer-Peppas plot to a major extent.  
 
Scanning electron microscope (SEM) 
SEM photomicrographs of optimized formulations as 
shown in figure 6 and 7 were used to examine the 
detailed structures of the inside of SPH in the dry 
states. The pore size is approximately 100 µm, and 
the pores are all interconnected. 
 
 
Figure 7. SEM structure of optimized batch 
[CH4f] inner surface. 
Conclusion 
On the basis of swelling time (3 min) and swelling 
ratio (85.57±0.4%), mechanical strength (320mg) 
apparent density (0.73±0.5), and in vitro drug release 
(97.77±0.33%) the optimized batch was found to be 
CH4f, at optimum 2.5% w/v Bis and 175 mg Ac-Di-
Sol, which is suitable for gastric retention. 
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